Gut Microbiota in Cardiovascular Health and Disease

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Circulation Research

• Publication date

  2017-03-31

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1161/CIRCRESAHA.117.309715PMID 28360349PMCID PMC5390330
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Retraction and Republication: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N Engl J Med 2013;368:1279-90.

  2018cited by this paper
• Gut microbiome in chronic kidney disease: challenges and opportunities

  2017cited by this paper
• High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice

  2017cited by this paper
• Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors

  2017cited by this paper
• Alterations in the gut microbiota can elicit hypertension in rats.

  2017cited by this paper
• Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus.

  2017cited by this paper
• Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke

  2017cited by this paper
• Hypertension-Linked Pathophysiological Alterations in the Gut

  2017cited by this paper
• Trimethylamine N-oxide and Risk Stratification after Acute Myocardial Infarction.

  2017cited by this paper
• Increased Systolic and Diastolic Blood Pressure Is Associated With Altered Gut Microbiota Composition and Butyrate Production in Early Pregnancy

  2016cited by this paper
• Pathogenic Gut Flora in Patients With Chronic Heart Failure.

  2016cited by this paper
• Trimethylamine N‐Oxide Promotes Vascular Inflammation Through Signaling of Mitogen‐Activated Protein Kinase and Nuclear Factor‐κB

  2016cited by this paper
• Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association

  2016cited by this paper
• Trimethylamine N‐Oxide and Mortality Risk in Patients With Peripheral Artery Disease

  2016cited by this paper
• Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk.

  2016cited by this paper
• Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden.

  2016cited by this paper
• The microbiome in early life: implications for health outcomes

  2016cited by this paper
• Modulation of a Circulating Uremic Solute via Rational Genetic Manipulation of the Gut Microbiota.

  2016cited by this paper
• Acetate mediates a microbiome-brain-β cell axis promoting metabolic syndrome

  2016cited by this paper
• Choline Diet and Its Gut Microbe–Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload–Induced Heart Failure

  2016cited by this paper
• Gut Microbiota Promote Angiotensin II–Induced Arterial Hypertension and Vascular Dysfunction

  2016cited by this paper
• Coronary Plaque Characterization Assessed by Optical Coherence Tomography and Plasma Trimethylamine-N-oxide Levels in Patients With Coronary Artery Disease.

  2016cited by this paper
• Intestinal Microbial Metabolites Are Linked to Severity of Myocardial Infarction in Rats

  2016cited by this paper
• Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

  2015cited by this paper
• Gut Microbiota-Dependent Trimethylamine N-Oxide (TMAO) Pathway Contributes to Both Development of Renal Insufficiency and Mortality Risk in Chronic Kidney Disease

  2015influential reference
• The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance.

  2015cited by this paper
• Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.

  2015cited by this paper
• The Altered Schaedler Flora: Continued Applications of a Defined Murine Microbial Community.

  2015cited by this paper
• Quantifying Diet-Induced Metabolic Changes of the Human Gut Microbiome.

  2015cited by this paper
• Evidence for a link between gut microbiota and hypertension in the Dahl rat.

  2015cited by this paper
• Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation

  2015cited by this paper
• Short-Chain Fatty Acids Protect Against High-Fat Diet–Induced Obesity via a PPARγ-Dependent Switch From Lipogenesis to Fat Oxidation

  2015cited by this paper
• Intake of Lactobacillus reuteri Improves Incretin and Insulin Secretion in Glucose-Tolerant Humans: A Proof of Concept

  2015cited by this paper
• Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis.

  2015influential reference
• The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids

  2015cited by this paper
• Personalized Nutrition by Prediction of Glycemic Responses.

  2015cited by this paper
• Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.

  2015cited by this paper
• Gut Dysbiosis Is Linked to Hypertension

  2015cited by this paper
• Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis[S]

  2015cited by this paper
• Diet dominates host genotype in shaping the murine gut microbiota.

  2015cited by this paper
• Impact of antibiotics on arterial blood pressure in a patient with resistant hypertension - A case report.

  2015cited by this paper
• Oral microbiota in patients with atherosclerosis.

  2015cited by this paper
• The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases.

  2015cited by this paper
• Global , regional , and national age – sex specifi c all-cause and cause-specifi c mortality for 240 causes of death , 1990 – 2013 : a systematic analysis for the Global Burden of Disease Study 2013

  2015cited by this paper
• Antihypertensive effects of probiotics Lactobacillus strains in spontaneously hypertensive rats.

  2015cited by this paper
• Intestinal blood flow in patients with chronic heart failure: a link with bacterial growth, gastrointestinal symptoms, and cachexia.

  2014cited by this paper
• Diet and the development of the human intestinal microbiome

  2014cited by this paper
• Probiotic Administration Attenuates Myocardial Hypertrophy and Heart Failure After Myocardial Infarction in the Rat

  2014cited by this paper
• Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis.

  2014cited by this paper
• Microbial Diversity Similarities in Periodontal Pockets and Atheromatous Plaques of Cardiovascular Disease Patients

  2014cited by this paper
• Dietary effects on human gut microbiome diversity

  2014cited by this paper
• Expansion of Urease- and Uricase-Containing, Indole- and p-Cresol-Forming and Contraction of Short-Chain Fatty Acid-Producing Intestinal Microbiota in ESRD

  2014cited by this paper
• Trimethylamine-N-oxide: a carnitine-derived metabolite that prolongs the hypertensive effect of angiotensin II in rats.

  2014cited by this paper
• Glucagon-like peptide 1 and the cardiovascular system.

  2014cited by this paper
• Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis.

  2014cited by this paper
• Transmission of Atherosclerosis Susceptibility with Gut Microbial Transplantation*

  2014cited by this paper
• FXR is a molecular target for the effects of vertical sleeve gastrectomy

  2014influential reference
• Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men

  2014cited by this paper
• Gut Bacterial Translocation May Aggravate Microinflammation in Hemodialysis Patients

  2014cited by this paper
• The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism

  2014cited by this paper
• Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.

  2014cited by this paper
• The contributory role of gut microbiota in cardiovascular disease.

  2014cited by this paper
• Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity.

  2014cited by this paper
• Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults

  2014cited by this paper
• γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO.

  2014cited by this paper
• Human genetics shape the gut microbiome.

  2014cited by this paper
• Diet alters probiotic Lactobacillus persistence and function in the intestine.

  2014cited by this paper
• Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits.

  2014cited by this paper
• A novel SCFA receptor, the microbiota, and blood pressure regulation

  2014cited by this paper
• Role of enteric neurotransmission in host defense and protection of the gastrointestinal tract.

  2014cited by this paper
• Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide.

  2014cited by this paper
• Effect of Probiotics on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials

  2014cited by this paper
• Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity

  2013cited by this paper
• p-Cresyl sulfate promotes insulin resistance associated with CKD.

  2013cited by this paper
• Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation

  2013cited by this paper
• Renal and cardiovascular sensory receptors and blood pressure regulation.

  2013cited by this paper
• A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome

  2013cited by this paper
• Diet rapidly and reproducibly alters the human gut microbiome

  2013cited by this paper
• Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

  2013cited by this paper
• Gut metagenome in European women with normal, impaired and diabetic glucose control

  2013influential reference
• p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase.

  2013cited by this paper
• Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist.

  2013cited by this paper
• Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.

  2013influential reference
• Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.

  2013cited by this paper
• FMT: First Step in a Long Journey

  2013cited by this paper
• Norovirus Gastroenteritis After Fecal Microbiota Transplantation for Treatment of Clostridium difficile Infection Despite Asymptomatic Donors and Lack of Sick Contacts

  2013cited by this paper
• Mechanisms underlying weight loss after bariatric surgery

  2013cited by this paper
• Chronic kidney disease alters intestinal microbial flora.

  2013cited by this paper
• Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity

  2013cited by this paper
• Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation.

  2013cited by this paper
• Primary Prevention of Cardiovascular Disease with a Mediterranean Diet

  2013cited by this paper
• Infant antibiotic exposures and early-life body mass

  2013cited by this paper
• Primary prevention of cardiovascular disease with a Mediterranean diet.

  2013cited by this paper
• The gut microbiome: the role of a virtual organ in the endocrinology of the host.

  2013cited by this paper
• A combined epidemiologic and metabolomic approach improves CKD prediction.

  2013cited by this paper
• Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection.

  2013cited by this paper
• Duodenal infusion of donor feces for recurrent Clostridium difficile.

  2013cited by this paper
• Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids.

  2013cited by this paper
• Supplemental materials for: Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis

  2013cited by this paper
• The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43

  2013cited by this paper

• Gut Microbiota and Short-Chain Fatty Acids in Cardiometabolic HFpEF: Mechanistic Pathways and Nutritional Therapeutic Perspectives

  2026influential citation
• Unlocking the secrets of gut microbiota: The untapped potential of Caenorhabditis elegans.

  2026cites this paper
• Inflammatory bowel disease through the lens of microbe-host interactions: immunomodulation, metabolic effects, and genetic susceptibility in microbiota dysbiosis.

  2026cites this paper
• Flavonoids and Their Influence on the Gut Microbiome: Implications for Cardiovascular Health

  2026cites this paper
• Gut Microbiome Strategies for Enhancing ICI Delivery Across the BBB in Glioblastoma

  2026cites this paper
• Network Pharmacology-Based Exploration: Non-Targeted Metabolites of Lactobacillus-Fermented Chaenomeles speciosa (Sweet) Nakai, Smilax glabra Roxb. and Pueraria montana var. Lobata in Uric Acid Metabolism Intervention.

  2026cites this paper
• Metabolic Inflammation as a Common Thread in Cardio-Endocrine Diseases: Toward a Unified Therapeutic Framework.

  2026cites this paper
• Intestinal Fatty Acid Binding Protein (I-FABP) in Heart Failure: A Comprehensive Review of its Role as a Biomarker and Mediator in Cardiac Dysfunction.

  2026cites this paper
• Clostridium butyricum ameliorates atherosclerotic inflammation through regulation of gut microbiota.

  2026cites this paper
• 3-Hydroxystearic acid promotes cholesterol efflux and attenuates atherosclerosis via the ALKBH5/PAX-8/ABCA1 pathway

  2026cites this paper
• Apple pomace flour fractions as functional ingredients: compositional and bioactivity profiling.

  2026cites this paper
• Ergothioneine attenuates whole-abdominal irradiation-induced multi-organ injury via the gut-heart-brain axis by modulating calcium voltage-gated channel subunit alpha1 C (Cacna1c) expression

  2026cites this paper
• Gut microbiota, sleep quality, and cognitive function in adults: A systematic review.

  2026cites this paper
• Gut-inflammation-SPARC axis associates with mobility decline in congestive heart failure.

  2026cites this paper
• Comparative insights into the gut–heart axis: cross-species and cross-population perspectives

  2026cites this paper
• Distinct Gut Microbiome Profiles Underlying Cardiometabolic Risk Phenotypes in Individuals with Obesity

  2026cites this paper
• Reliable detection of Host-Microbe Signatures in cancer using PRISM.

  2026cites this paper
• Night shift work, dietary patterns, and coronary heart disease.

  2026cites this paper
• Harnessing the gut-heart axis for cardiovascular drug innovation: microbiome, metabolites, and personalized treatment strategies.

  2026cites this paper
• The gut microbiota: an emerging therapeutic target for ICI-associated myocarditis.

  2026cites this paper
• Gut microbiota and metabolic pathway profiles in infected and non-infected heart transplant patients before and after surgery

  2026cites this paper
• Bridging Traditional Chinese Medicine and Modern Science: The Gut-Zang-Fu Axis and its Scientific Advances

  2026cites this paper
• Alterations in cardiovascular biomarkers and gut microbiome associated with night shift work: Insights from the Chinese Platform Workers Study.

  2026cites this paper
• Gut Microbiota–Leptin crosstalk in obesity and metabolic dysregulation

  2026cites this paper
• Influence of the origin of dietary proteins (plant vs. animal) on the faecal microbiota of older adults.

  2026cites this paper
• Hypoxic responsiveness and gut fermentation capacity in heart failure patients: preliminary results

  2026cites this paper
• Influence of Yoga-based cardiac rehabilitation on gut-microbiome diversity and Gut–Heart–Brain axis (YoGH-Biome) in heart failure: a study protocol

  2026cites this paper
• A metagenomic study of the gut microbiome in patients with type 2 diabetes mellitus and myocardial infarction.

  2026cites this paper
• Heart Failure in the Molecular Era: Redefining Our Understanding of Disease Mechanisms and Perspectives.

  2026cites this paper
• Apolipoprotein M: Structural Insights, Functional Roles and Therapeutic Approaches in Vascular Disease.

  2026cites this paper
• Phytochemicals‐Mediated Gut Microbiota Regulation: A Comprehensive Review of Therapeutic Strategies for Cardiovascular Diseases

  2026cites this paper
• Gut microbiota-dependent anti-inflammatory mechanisms of berberine in ameliorating hypertension: role of SCFAs, LPS reduction, and STAT3 signaling

  2026cites this paper
• Morchella polysaccharide ameliorates myocardial infarction inflammation in mice through increasing gut microbiota-derived 12-HEPE.

  2026cites this paper
• Butyrate ameliorates doxorubicin-induced heart failure by inhibiting cardiomyocyte ferroptosis through the gut-heart axis

  2026cites this paper
• Association between gut microbiota-derived TMAO, systemic inflammatory markers, and echocardiographic findings in patients with common variable immunodeficiency

  2026cites this paper
• Exploring the basis of Traditional Chinese Medicine in treating cardiovascular disease: insights into the microbiota-gut-heart axis

  2026cites this paper
• The Gut–Heart Axis: A Comprehensive Review of Microbiota’s Role in Cardiovascular Health and Disease and Emerging Therapeutic Strategies

  2026cites this paper
• Xiong's Shiwei Wendan decoction attenuates plaque lesions and balances gut microbiota dysbiosis in ApoE-/- mice with high-fat diet.

  2025cites this paper
• GUT-HEART-BRAIN AXIS: UNDERSTANDING THE INTERPLAY IN PATIENTS WITH CONGENITAL HEART DISEASE

  2025cites this paper
• Right Ventricular Function, Inflammation, and the Gut Microbiome in Pulmonary Hypertension: A Translational Frontier.

  2025cites this paper
• Diabetes-induced depression: unravelling the role of gut dysbiosis

  2025cites this paper
• Interaction Between Gut-Heart Axis in Sepsis-Induced Cardiomyopathy.

  2025cites this paper
• Exploring the Multitude: A Review on Different Categorization of Probiotics.

  2025cites this paper
• Microbiota in Gut‐Heart Axis: Metabolites and Mechanisms in Cardiovascular Disease

  2025cites this paper
• Gut-Heart Axis: The Role of Gut Microbiota and Metabolites in Heart Failure

  2025cites this paper
• Exploring the research progression and evolutionary trends of gut microbiome and hypertension: a bibliometric analysis

  2025cites this paper
• Gut microbiota-derived metabolite phenylacetylglutamine in cardiovascular and metabolic disease.

  2025cites this paper
• Mechanisms and intervention strategies of TMAO (Trimethylamine NOxide) in abdominal aortic aneurysm.

  2025cites this paper
• Impact of chronic consumption of probiotics, oats, and apples on expression of genes related to bile acids, lipid, gut peptides, and inflammation in peripheral monocular cells - findings from the CABALA study

  2025cites this paper
• Dietary methionine restriction ameliorates atherosclerosis by remodeling the gut microbiota in apolipoprotein E-knockout mice.

  2025cites this paper
• The aspartate superpathway in gut microbiota-related metabolic pathways mediates immune cell protection against COPD and IPF: a Mendelian randomization analysis

  2025cites this paper
• High temperature and ozone co-exposure induces cardiovascular damage in mice: Insights from gut microbiome and plasma metabolomics.

  2025cites this paper
• Aging at the Crossroads of Organ Interactions: Implications for the Heart

  2025cites this paper
• Insights Into Heart-Tumor Interactions in Heart Failure

  2025cites this paper
• ZeXieYin formula alleviates atherosclerosis by regulating SBAs levels through the FXR/FGF15 pathway and restoring intestinal barrier integrity

  2025cites this paper
• Microbiome and cardiovascular health unexplored frontiers in precision cardiology: a narrative review

  2025cites this paper
• Gut microbiota, metabolites, and pulmonary hypertension: Mutual regulation and potential therapies.

  2025cites this paper
• Association between serum short-chain fatty acid levels and the risk of all-cause and cardiovascular disease mortality in Chinese patients undergoing maintenance hemodialysis: a retrospective cohort study

  2025cites this paper
• Gut Feelings: How Microbes, Diet, and Host Immunity Shape Disease

  2025cites this paper
• Biomimetic nanocomplexes loading with evolocumab and curcumin for synergistic anti-atherosclerosis therapy in ApoE−/− mice

  2025cites this paper
• Gut Microbiota and COVID-19: Unraveling the Gut–Lung Axis and Immunomodulatory Therapies

  2025cites this paper
• Gut Microbiota‐Derived Trimethylamine N‐Oxide and the Risk of Diabetes: An Updated Systematic Review and Meta‐Analysis

  2025cites this paper
• High-phytosterol rapeseed oil prevents atherosclerosis by reducing intestinal barrier dysfunction and cholesterol uptake in ApoE-/- mice.

  2025cites this paper
• Crosstalk Between Bile Acids and Intestinal Epithelium: Multidimensional Roles of Farnesoid X Receptor and Takeda G Protein Receptor 5

  2025cites this paper
• Gut‐on‐a‐chip platforms: Bridging in vitro and in vivo models for advanced gastrointestinal research

  2025cites this paper
• Pharmacological Foundation and Novel Insights of Resveratrol in Cardiovascular System: A Review.

  2025cites this paper
• Sheng Mai San Modulates the Heart-Gut-Microbiota Axis to Mitigate Heat Stress-Induced Damage in Rats

  2025cites this paper
• Gut Microbiome Engineering for Diabetic Kidney Disease Prevention: A Lactobacillus rhamnosus GG Intervention Study

  2025cites this paper
• Interruptins Extracted from Cyclosorus terminans Protect Gut Pathologies Induced by High-Fat Diet in Rats

  2025cites this paper
• Pulsed electromagnetic fields treatment ameliorates cardiac function after myocardial infarction in mice and pigs

  2025cites this paper
• Exploring the Mechanism of Shengmai Guanxin Formula Regulating Intestinal Microbiota in the Treatment of Coronary Heart Disease Based on the Relationship between Heart and Small Intestine

  2025cites this paper
• The impact of early‐life and prolonged antibiotics exposure on 78 common diseases: Evidence from epidemiology

  2025cites this paper
• Assessment of the association between constipation and atherosclerosis in cardiovascular and cerebrovascular diseases: a systematic review and meta-analysis.

  2025cites this paper
• Risk of acute myocardial infarction in patients with non-typhoidal Salmonella infection: A nationwide matched population-based cohort study.

  2025cites this paper
• Xanthoceras sorbifolium Oil Attenuates Hyperlipidemia Through Dual Modulation of Gut Microbiota and Lipid Metabolites: Mechanistic Insights from Lipidomics and 16S rRNA Sequencing

  2025cites this paper
• Deciphering the association between gut microbiome and varicose veins: A mendelian randomization study

  2025cites this paper
• Evaluation of enzymatically hydrolyzed poultry byproduct meal effects on fecal microbiota and pressure variables in elderly obese cats

  2025cites this paper
• The heart of the matter: How gut microbiota-targeted interventions influence cardiovascular diseases.

  2025cites this paper
• High-throughput untargeted metabolomic profiling of urinary biomarkers in acute myocarditis patients: a cross-sectional study

  2025cites this paper
• Polystyrene Microplastics Can Aggravate the Damage of the Intestinal Microenvironment Caused by Okadaic Acid: A Prevalent Algal Toxin

  2025cites this paper
• Influence of Probiotic Bifidobacterium Capsules on Sleep Quality in Patients on Maintenance Hemodialysis.

  2025cites this paper
• Modified probiotics and the related combinatorial therapeutics

  2025cites this paper
• Akkermansia muciniphila extracellular vesicles: function and theranostic potential in disease

  2025cites this paper
• Ex Vivo Analysis of the Effect of Endoscopic Premedications on the Microbiota Profile in Gastric Juice

  2025cites this paper
• Cardiometabolic index and major depressive disorder: Stroke and diabetes as mediators.

  2025cites this paper
• The Critical Role of Faecalibacterium prausnitzii in Cardiovascular Diseases

  2025cites this paper
• The role of fiber in gut health and chronic diseases

  2025cites this paper
• Association of the gut microbe-dependent trimethylamine N-oxide and its precursors with risk of hypertension: a cross-sectional study in rural northeastern China.

  2025cites this paper
• Hypoglycemic and Gut Microbiota-Modulating Effects of Pectin from Citrus aurantium "Changshanhuyou" Residue in Type 2 Diabetes Mellitus Mice.

  2025cites this paper
• Targeting gut-immune-heart modulate cardiac remodeling after acute myocardial infarction.

  2025cites this paper
• Dietary Trends, Microbiome, and Cardiovascular Health: A Narrative Review

  2025cites this paper
• Gut commensal Bifidobacterium-derived extracellular vesicles modulate the therapeutic effects of anti-PD-1 in lung cancer

  2025cites this paper
• The single-cell atlas of short-chain fatty acid receptors in human and mice hearts

  2025cites this paper
• Unripe apple polyphenols extract improves intestinal inflammation and restructures gut microbiota in spontaneously hypertensive rats.

  2025cites this paper
• Decoding TMAO in the Gut-Organ Axis: From Biomarkers and Cell Death Mechanisms to Therapeutic Horizons

  2025cites this paper
• Risk Factors and Prevention of Cancer and CVDs: A Chicken and Egg Situation

  2025cites this paper
• Gut Microbiota Modulation by Lysozyme as a Key Regulator of Vascular Inflammatory Aging

  2025cites this paper
• Gut Microbiota and Cardiovascular Diseases: Unraveling the Role of Dysbiosis and Microbial Metabolites

  2025influential citation
• The Beneficial Use of Artemisia annua, Artemisinin, and Other Compounds in Animal Health

  2025cites this paper
• Akkermansia muciniphila exerts a protective effect on the development of abdominal aortic aneurysm by inhibiting inflammation

  2025cites this paper